Aethlon Medical Investor Relations Material
Latest events
Q4 2025
Aethlon Medical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aethlon Medical Inc
Access all reports
Aethlon Medical Inc develops medical devices focused on the removal of harmful substances from the blood. The company’s lead product, Hemopurifier, is designed to filter viruses, exosomes, and other pathogenic particles in therapeutic applications. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
AEMD
Country
🇺🇸 United States